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ABSTRACT 
Background: Anemia is a common finding in patients with diabetes and renal insufficiency but the effect of 
poor glycemic control in such patients is not clearly defined. 
Aim: To determine the impact of poor glycemic control in the incidence of anemia in type-2 diabetic patients 
with renal insufficiency. 
Methods: This cross-sectional study was conducted in 2012 and comprised 72 type-2 diabetic patients and 32 
non-diabetic controls recruited from diabetes clinics of the Igbinedion University Teaching Hospital, Okada, Edo 
state, Nigeria. Patients were divided into groups according to glycemic control and renal function. Serum 
creatinine, hemoglobin concentration, blood glucose and glycated hemoglobin of subjects were measured. The 
presence of anemia was defined by hemoglobin level <13.0 g/dL in men and <12.0 g/dL in women. Renal 
insufficiency was defined as serum creatinine level >1.5 mg/dL. 
Results: Incidence of anemia in the study population was 27%. Diabetic patients with poor glycemic control had 
greater odds (OR = 3.71; 95% CI, 1.09 – 12.56) for anemia compared to those with good glycemic control 
irrespective of renal function. Furthermore, patients with poor glycemic control and renal insufficiency were at a 
greater risk of anemia compared to those with normal renal function (OR = 5.78; 95% CI, 1.34 – 24.92). 
Conclusion: Higher incidence of anemia is associated with poor glycemic control especially in diabetic patients 
with renal insufficiency.  
Keywords: Anemia, Type-2 diabetes mellitus, Glycemic control, Renal insufficiency 
 
1. Introduction 
 
Anemia is the most common blood disorder and a common finding in patients with diabetes [1]. It is also 
considered as a key indicator of chronic kidney disease and an important cardiovascular risk factor [2, 3]. 
Previous studies have shown that the incidence of anemia in diabetic patients is mostly associated with the 
presence of renal insufficiency. Thus, patients with diabetes have a greater degree of anemia for their level of 
renal impairment than non-diabetic patients presenting with other causes of renal failure [1-5]. Poor glycemic 
control is one of the factors that have been implicated in the increased risk of anemia amongst diabetic patients 
with normal renal function in this population [6] and increased risk of cardiovascular disease amongst diabetic 
patients in other populations [7]. 
 
Limited information exists on the prevalence of anemia in diabetic patients with renal insufficiency in Nigeria. In 
addition, no previous studies from this population, to the best of our knowledge, have assessed the importance of 
glycemic control in this group of diabetic patients. We believe that a reduction of blood glucose levels and the 
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targeting of acceptable glycated haemoglobin levels would help reduce the risk of anemia in the diabetic 
population with (detected or undetected) renal dysfunction. This may be important especially at the primary care 
setting where routine laboratory investigations are infrequent and haematological tests are not usually included 
as part of the laboratory tests for the patients' management. 
 
The present study therefore aimed at examinining the relationship of anemia with diabetes and kidney function, 
and to determine whether this relationship differed between patients with good glycemic control and those with 
poor glycemic control. 
 
2. METHODS 
 
Subjects 
This cross sectional study comprised 106 subjects (74 type-2 diabetic patients and 32 non-diabetics). The 
diabetic patients were recruited from January to December 2012 and from diabetes clinics of the Igbinedion 
University Teaching Hospital, Okada, Edo state, Nigeria. Diabetes was diagnosed by participant’s self-report, 
and glycated hemoglobin values >6.5%. The diabetic patients were divided into groups according to: (a) 
glycemic control [patients with glycemic control (n = 30) and those with poor glycemic control (n = 44)] (b) 
renal function (patients with normal renal function, n = 34 and patients with renal insufficiency, n = 40). Patients 
with good glycemic control comprised those whose glycated hemoglobin concentration (HbA1c) was ≤7.5%. 
The poorly controlled diabetic comprised those whose HbA1c level was >7.5%. The apparently healthy non-
diabetic subjects were recruited from the same environment as the diabetic patients. Each volunteer underwent 
compulsory fasting blood glucose and glycated hemoglobin tests. Subjects with fasting blood glucose level >125 
mg/dl and glycated hemoglobin measurement > 6.5% were excluded from the non-diabetic subjects data. The 
non diabetic group was further divided according to their renal functions (non-diabetic with normal renal 
function, n = 20; and those with renal insufficiency, n = 12). Group designation, patients' demographics and 
clinical features are listed in Table1. 
 
Protocol 
To be included in the study all patients had to be 18 years of age or older. Exclusion criteria included those who 
had history of unstable cardiovascular and peripheral diseases; those with chronic illnesses; those with recent 
blood loss or donated blood recently; those who have hemolytic anemia or genetic differences in the hemoglobin 
molecule (hemoglobinopathy) such as sickle-cell disease and other systemic disorders that could result in 
anemia. Blood were collected from the subjects after obtaining permission from the hospital authority, and under 
aseptic conditions using fresh needles and syringes and sterile containers. Blood samples were collected into 
floride oxalate and EDTA bottles for serum creatinine, hematocrit, hemoglobin concentration, fasting blood 
glucose (FBG), and glycated hemoglobin measurements respectively. The presence of anemia was defined by a 
hemoglobin level <13.0 g/dL in men and <12.0 g/dL in women based on definition of World Health 
Organization (WHO) [8]. Renal function was considered insufficient if serum creatinine values were >1.5 mg/dL 
for men and >1.3 mg/dL for women [9]. Fasting blood glucose was estimated using the glucose oxidase method 
(Randox, United Kingdom). Glycated hemoglobin A1C was assessed by ion exchange chromatography method 
(DIALAB, Gieselhaft, Germany). The Research and Ethics Committees of the institution approved the study and 
all the subjects gave their written informed consent prior to the study. 
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3. RESULTS 
 
Table 1. Demographic and clinical characteristics of subjects 
Variables Non-diabetics 
(n= 32) vs. Diabetics 
(n=74) 
Patients with good 
glycemic control (n=30) 
vs. Patients with poor 
glycemic control (n=44) 
Diabetics with normal renal 
function (n=34) vs.  
Diabetics with renal 
insufficiency (n=40) 
Age (yrs) 
 
 
Sex (M/F 
Ratio) 
 
HbA1c (%) 
 
 
FBG (mg/dl) 
 
 
SCr (mg/dl) 
 
 
Hemoglobin 
(g/dl) 
 
Hematocrit 
(%) 
36.28 ± 11.53***     
vs. 45.44 ± 11.99 
 
19/13 vs. 38/36 
 
 
5.73 ± 0.45***     
vs. 10.33 ± 4.59 
 
77.22 ± 10.15***         
 vs. 147.01 ± 58.36 
 
1.49 ± 1.12**     
vs. 2.49 ± 1.89 
 
13.22 ± 0.92**     
vs. 12.35 ± 1.33 
 
41.78 ± 4.70**     
vs. 38.40 ± 6.80 
37.13 ± 9.89***     
vs. 51.11 ± 9.85 
 
13/17 vs. 25/19 
 
 
5.95 ± 0.48***     
vs. 13.32 ± 3.65 
 
86.30 ± 15.66***     
vs. 188.41 ± 35.94 
 
1.53 ± 0.88***     
vs. 3.05 ± 2.14 
 
12.95 ± 0.94***     
vs. 11.94 ± 1.41 
 
41.0 ± 4.56**     
vs. 36.63 ± 7.52 
45.50 ± 11.60 
vs. 45.40 ± 12.46 
 
20/14 vs. 18/22 
 
 
9.94 ± 5.33 
vs. 10.67 ± 3.89 
 
128.64 ± 58.95* 
vs. 162.62 ± 53.77 
 
0.92 ± 0.24***     
vs. 3.72 ± 1.70 
 
12.81 ± 0.90**     
vs. 11.95 ± 1.51 
 
41.26 ± 4.80***     
vs. 35.97 ± 7.34 
Abreviations: HbA1c = Glycated hemoglobin concentration; FBG = Fasting blood glucose; SCr = Serum 
creatinine; *P < 0.05; **P < 0.01; ***P < 0.001. Data are means ± standard deviations. 
 
Demographic and clinical characteristics of patients are as shown in Table 1. Mean hemoglobin as well as the 
mean hematocrit values were significantly higher in non-diabetics compared to diabetics (P < 0.01); also in 
persons with good glycemic control compared to persons with poor glycemic control (P < 0.001 and P < 0.01) 
and in diabetic patients with normal renal function compared to those with renal insufficiency (P < 0.01 and P < 
0.001) respectively. Significantly higher serum creatinine was noted in diabetics compared to non-diabetics and 
in patients with poor glycemic control compared to those with good glycemic control (P < 0.01 and p < 0.001) 
respectively. Mean HbA1c did not differ between diabetic patients with normal renal function and those with 
renal insufficiency. On the other hand, fasting blood glucose was significantly higher (P < 0.05) in diabetics with 
renal insufficiency compared to those with normal renal function. 
 
The incidence of anemia in the study population (n = 106) was 21.7% (n = 23). Of the 74 diabetic patients who 
participated in the stduy, 27% (n = 20) had anemia. Patients with diabetes had significantly more anemia 
compared to the non-diabetic patients (18.9% vs. 2.8%; P<0.001). Chi-square test indicated significant (X2 = 
12.56; p = 0.000) difference in the incidence of anemia between non-diabetics and diabetic patients. Logistic 
regression further revealed that those who are diabetic are at greater risk of anemia compared to non-diabetics 
(OR = 3.58; 95% CI, 1.0 – 13.06). 
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Table 2. Incidence of anemia in diabetic patients according to renal function  
 DIABETICS WITH NORMAL 
RENAL FUNCTION 
N (%) 
DIABETICS WITH RENAL 
INSUFFICIENCY 
N (%) 
TOTAL 
 
 
N (%) 
X2 P-
VALUE 
No 
Anemia 
 
Anemia 
 
Total 
30 (40.5) 
 
 
4 (5.4) 
 
34 (45.9) 
24 (32.5) 
 
 
16 (21.6) 
 
40 (54.1) 
54(73.0) 
 
 
20(27.0) 
 
74 (100) 
 
 
7.4 
 
 
0.006 
 
Among the diabetic patients, 45.9% had normal renal function, while 54.1% had evidence of renal insufficiency 
(Table 2). Patients with renal insufficiency had significantly greater incidence of anemia than those with normal 
renal function (21.6% vs. 5.4%; P = 0.007). Furthermore, a significant association was observed between 
prevalence of anemia and renal function (X2 = 7.4; P < 0.01). Diabetic patients with renal insufficiency were 
more likely to develop anemia compared to those with normal renal function (OR = 5.0; 95% CI, 1.47 -16.93). 
 
Table 3. Incidence of anemia in diabetic patients according to glycemic control status 
 GOOD GLYCEMIC 
CONTROL 
N (%) 
POOR GLYCEMIC 
CONTROL 
N (%) 
TOTAL 
 
 
N (%) 
X2 P-
VALUE 
No 
Anemia 
 
Anemia 
 
Total 
26 (35.1) 
 
 
4 (5.4) 
 
30 (40.5) 
28 (37.9) 
 
 
16 (21.6) 
 
44 (59.5) 
54(73.0) 
 
 
20(27.0) 
 
74 (100) 
 
4.79 
 
0.03 
 
Among the 74 diabetic patients, 40.5% (n = 30) had good glycemic control and 59.5% (n = 44) had poor 
glycemic control (Table 3). Those with poorly controlled diabetes had significantly higher incidence of anemia 
than those with good glycemic control (21.6% vs. 5.4%; P = 0.007). Greater risk of anemia was also observed in 
those with poorly controlled diabetes compared to those with good glycemic control (OR = 3.71; 95% CI, 1.09 – 
12.56). 
 
Table 4. Incidence of anemia in diabetic patients with poor glycemic control according to renal function status.  
 PGC WITH NORMAL 
RENAL FUNCTION 
N (%) 
PGC WITH RENAL 
INSUFFICIENCY 
N (%) 
TOTAL 
 
N (%) 
X2 P-
VALUE 
No 
Anemia 
 
Anemia 
 
Total 
16 (36.4) 
 
 
3 (6.8) 
 
19 (43.2) 
12 (27.3) 
 
 
13 (29.5) 
 
25 (56.8) 
28(63.6) 
 
 
16(36.4) 
 
44 (100) 
 
6.12 
 
0.013 
 
43.2% of diabetic patients with poor glycemic control had normal renal function, while 56.8% had renal 
insufficiency (Table 4). Significant difference was observed between the incidence of anemia in patients with 
poor glycemic control but normal renal function compared to those with poor glycemic control and renal 
insufficiency (29.5% vs. 6.8%; P = 0.01) among diabetics with normal renal function. Similarly patients with 
poor glycemic control and renal insufficiency were found to be at a greater risk of anemia compared to those 
with normal renal function (OR = 5.78; 95% CI, 1.34 – 24.92). 
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Table 5. Incidence of anemia in diabetic patients with renal insufficiency according to glycemic control status  
 GGC WITH RENAL 
INSUFFICIENCY 
N (%) 
PGC WITH RENAL 
INSUFFICIENCY 
N (%) 
TOTAL 
 
N (%) 
X2 P-
VALUE 
No 
Anemia 
 
Anemia 
 
Total 
12 (30.0) 
 
 
3 (7.5) 
 
15 (37.5) 
12 (30.0) 
 
 
13 (32.5) 
 
25 (62.5) 
24(60.0) 
 
 
16(40.0) 
 
40 (100) 
 
4.0 
 
0.04 
 
Table 5 shows the incidence of anemia in diabetic patients with renal insufficiency according to glycemic 
control status. 62.5% of this group of patients had poor glycemic control, while 37.5% had good glycemic 
control. The incidence of anemia was significantly higher in patients with poor glycemic control compared to 
those with good glycemic control (32.5% vs. 7.5%; P = 0.01). Logistic regression also indicated that patients 
with poor glycemic control were at greater risk of anemia than those with good glycemic control (OR = 4.33; 
95% CI, 1.01 – 19.20). 
 
Table 6. Indices of glycemic control, renal function and anemic condition compared between diabetic patients 
with and without anemia 
VARIABLES NON-ANEMIC  
N = 54 
ANEMIC 
N = 20 
t-STAT P-VALUE 
FBG 
 
HbA1c (%) 
 
SCr (mg/dl) 
 
Hb (g/dl) 
 
Hematocrit (%) 
135.61±56.44 
 
7.70 ± 1.98 
 
2.03 ± 1.68 
 
13.06 ± 0.58 
 
41.87 ± 3.21 
177.80±53.22 
 
11.69 ± 3.82 
 
3.51 ± 2.03 
 
10.43 ± 0.74 
 
29.05 ± 4.77 
-2.89 
 
-4.45 
 
-2.89 
 
14.38 
 
11.11 
0.005 
 
0.000 
 
0.007 
 
0.000 
 
0.000 
Abreviations: HbA1c = Glycated hemoglobin concentration; SCr = Serum creatinine; Hb = Hemoglobin. Data 
are means ± standard deviations. 
 
Patients with anemia had significantly greater FBG, HbA1C and SCr levels compared to patients without anemia 
(177.80 vs. 135.61, P = 0.005; 11.69 vs. 7.70, P = 0.000 and 3.51 vs. 2.03, P = 0.007) respectively. The same 
trend was observed when hemoglobin and hematocrit values were compared between patients with and without 
anemia (Table 6). 
 
Age and sex adjusted Pearson’s correlation analysis indicated a significant negative associations between 
hemoglobin concentration and; serum creatinine level (r = -0.366; p = 0.002); fasting blood glucose (r = -0.337; 
p = 0.004) and glycated hemoglobin concentration (r = -0.568; p = 0.000). 
 
4. DISCUSSION 
The present study indicated a high prevalence of anemia (27%) among diabetic patients irrespective of sex, renal 
function and glycemic control status. Our data indicated a higher prevalence of anemia when compared to 
previous studies by Carwood et al (males, 11%; feamles, 16%) [10],  Thomas et al (20%) [11], Craig et al 
(17.8%) [12], and Bonakdaran et al (19.6%) [13]. The higher incidence of anemia in our study may be due to the 
small sample size of our study, which also constitutes a large proportion (34%, n = 25) of patients who had 
poorly controlled diabetes as well as renal insufficiency. This category of diabetic patients has been shown to be 
more susceptible to impaired erythropoietin production and release and higher incidence of anemia [14, 15]. 
 
The presence of anemia was significantly higher in diabetic patients compared to non-diabetic subjects. Those 
who were diabetic were also found to be 3.5 times at greater risk of anemia than those without anemia. The 
present study also indicated negative correlation between hemoglobin concentration (an index for anemic 
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condition) and fasting blood glucose (index for diabetes). These findings strengthen previous studies which have 
reported higher prevalence of anemia in diabetic compared to non diabetic patients irrespective of the status of 
renal function [1, 2, 3, 16]. In addition, diabetic patients with renal insufficiency had more anemia and were at 
greater risk of anemia compared to patients with normal renal function. Negative correlations between 
hemoglobin concentration and serum creatinine (index of renal function) were also observed.  Previous studies 
have associated diabetic patients who had renal insufficiency with higher prevalence of anemia compared to 
those with normal renal function [13, 17, 18]. Our study however is significant since it excluded those who have 
hemolytic anemia or genetic differences in the hemoglobin molecule (hemoglobinopathy) such as sickle-cell 
disease and other systemic disorders that could result in anemia. 
 
Reducing blood glucose levels and targeting acceptable glycated haemoglobin (HbA1c) levels is the major focus 
in preventing the risk of micro- and macro-vascular complications [19]. Our findings indicated that irrespective 
of renal function, patients with poor glycemic control were at greater odds of anemia than those with good 
glycemic control. In patients with renal insufficiency, data indicated that those with poor glycemic control were 
at greater risk of anemia than those with controlled diabetes. Negative correlation was also observed between 
glycated hemoglobin (an index of glycemic control) and hemoglobin concentration. Previous studies in diabetic 
patients with normal renal function have demonstrated higher prevalence of anemia in those with uncontrolled 
diabetes compared to those with controlled diabetes [6, 14]. The risk of anemia in diabetics with poor glycemic 
control has been previously associated with diabetic autonomic neuropathy leading to impaired erythropoietin 
production and release [15, 20]. This condition may be worsened in poor glycemic control patients with renal 
insufficiency due to damage to renal achitecture produced by chronic hyperglycemia and consequent formation 
of advanced glycation end products [1, 2, 21] and may explain the present findings. Our study therefore 
underscores the importance of glycemic control in reducing the risk of anemia in the diabetic population, 
particularly in those with renal impairments and preventing other diabetic complications. 
 
In conclusion, anemia is associated with poor glycemic controlparticularly in diabetic patients with renal 
insufficiency. This calls for the inclusion of routine hematological tests as treatment criteria for diabetes and 
taking into consideration the consequences of poor glycemic control and renal dysfunction, in order to make 
optimal therapeutic decisions for the treatment of diabetes mellitus in adults and prevent other diabetic 
complications. 
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